Basic and Diluted Loss Per Share (Tables)

9 Months Ended

Mar. 31, 2026

Basic and Diluted Loss Per Share [Abstract]

Schedule of Basic and Diluted Loss Per Share

The following table presents the computation of basic and diluted loss per share attributable to common stockholders, for the periods presented:

		For the Three Months Ended March 31,								For the Nine Months Ended March 31,
		2026				2025				2026				2025
		(Unaudited)				(Unaudited)				(Unaudited)				(Unaudited)
Net loss– basic and diluted EPS		$	(36,269,993	)		$	(4,084,511	)		$	(43,421,349	)		$	(4,927,154	)

Basic and diluted weighted average shares outstanding*			6,989,278				7,050,260				6,886,673				5,937,756

Basic and diluted loss per share		$	(5.19	)		$	(0.58	)		$	(6.31	)		$	(0.83	)

*	There were no shares that have a dilutive effect for the three and nine months ended March 31, 2026 and 2025.

Schedule of Dilutive Common Share Equivalents Outstanding Excluded in Diluted Net Loss Per Share Calculation

The following table outlines dilutive common share equivalents outstanding, which are excluded in the above diluted net loss per share calculation, as the effect of their inclusion would be anti-dilutive or the share equivalents were contingently issuable as of each period presented:

		For the Three Months Ended March 31,								For the Nine Months Ended March 31,
		2026				2025				2026				2025
		(Unaudited)				(Unaudited)				(Unaudited)				(Unaudited)
Earnout Shares*			-				2,100,000				-				2,100,000
Warrants **			12,145,917				12,145,917				12,145,917				12,145,917
RSUs**			427,944				727,009				427,944				727,009
Total			12,573,861				14,972,926				12,573,861				14,972,926

*

As described in Note 4 - Reverse recapitalization, the Earnout Shares that are contingently issuable in connection with the Business Combination are subject to vesting based on the Company’s financial performance during the earnout period. The Earnout Shares are excluded from the calculation of basic and diluted weighted-average number of common shares outstanding until vested.

**	The Company’s outstanding warrants and RSUs were excluded from the computation of diluted EPS because it has anti-dilutive effect as the company had a net loss during the periods presented.